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Abstract: The O-antigen polysaccharide (OPS) of Rhizobium etli CE3 lipopolysaccharide (LPS) 
is linked to the core oligosaccharide via an N-acetylquinovosaminosyl (QuiNAc) residue. A 
mutant of CE3, CE166, produces LPS with reduced amounts of OPS, and a suppressed mutant, 
CE166α, produces LPS with nearly normal OPS levels. Both mutants are deficient in QuiNAc 
production. Characterization of OPS from CE166 and CE166α showed that QuiNAc was 
replaced by its 4-keto derivative, 2-acetamido-2,6-dideoxyhexosyl-4-ulose. The identity of this 
residue was determined by NMR and mass spectrometry, and by gas chromatography-mass 
spectrometry analysis of its 2-acetamido-4-deutero-2,6dideoxyhexosyl derivatives produced by 
reduction of the 4-keto group using borodeuteride. Mass spectrometric and methylation analyses 
showed that the 2-acetamido-2,6-dideoxyhexosyl-4-ulosyl residue was 3-linked and attached to 
the core-region external Kdo III residue of the LPS, the same position as that of QuiNAc in the 
CE3 LPS. DNA sequencing revealed that the transposon insertion in strain CE166 was located in 
an open reading frame whose predicted translation product, LpsQ, falls within a large family of 
predicted open reading frames, which includes biochemically characterized members that are 
sugar epimerases and/or reductases. A hypothesis to be tested in future work is that lpsQ 
encodes UDP-2-acetamido-2,6-dideoxyhexosyl-4-ulose reductase, the second step in the 
synthesis of UDP-QuiNAc from UDP-GlcNAc.  
 
The bacterial species Rhizobium etli forms a nitrogen-fixing symbiosis with bean 
(Phaseolus vulgaris). During the symbiotic interaction of R. etli with bean, the bacteria eventually 
penetrate the root nodule cells via a plant-derived infection thread and are, thus, surrounded by 
the plant plasma membrane upon entering the nodule cell. The R. etli lipopolysaccharide (LPS)1 
plays an essential role in the infection of the host cells. Mutants that lack the O-chain 
polysaccharide (OPS) of the LPS or have reduced amounts of OPS fail to infect the host cells, 
resulting in root nodules that are devoid of bacteria and are unable to fix nitrogen (1–3). Similar 
results have also been observed for LPS mutants of R. leguminosarum biovar viciae, and 
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Bradyrhizobium japonicum (for a review, see Ref. 4).  
The complete glycosyl sequence of the R. etli parent strain OPS (5) and core region (6, 7) 
is shown in Fig. 1. The parent OPS consists of exactly five trisaccharide repeating units, 
composed of one residue each of fucose (Fuc), 3-O-methyl-6-deoxytalose (3Me6dTal), and 
methylglucuronate (GlcAMe). Considerable structural heterogeneity exists due to variability in 
the degree of endogenous O-methylation at fucosyl residues and due to partial loss of O-acetyl 
and methyl ester groups during mild acid hydrolysis or while in solution. As depicted in Fig. 1, the 
OPS repeating units are “capped” at the nonreducing end by a single residue of tri- or 
di-O-methylfucose (2,3,4-TOMeFuc or 2,3-DOMeFuc). The repeating unit located toward the 
proximal end of the OPS is attached to a nonrepeating glycosyl sequence, defined as the outer 
core region, consisting of fucose, mannose, and N-acetylquinovosamine (QuiNAc) (residues 
B–D); the QuiNAc residue of this outer core trisaccharide links the OPS repeating units to O-4 of 
the 3-deoxy-2-octulosonic acid (Kdo) III residue, itself uniquely located at the distal end of the 
inner core region.  
A mutant of R. etli CE3 that produces an LPS with reduced amounts of OPS is CE166. 
This mutant also fails to invade the root nodule cells (8), and analysis of its LPS showed that it 
lacked QuiNAc (8). The amount of OPS could be restored to nearly normal levels by suppression 
with multiple copies of a plasmid containing the lpsα region, which contains numerous genes 
encoding for the synthesis of the OPS but does not contain the gene mutated in CE166. The 
suppressed mutant, called CE166α, is able to form nitrogen-fixing nodules, but they form more 
slowly and are more widely dispersed on the host root compared with nodules formed by the 
parent, CE3 (8). The LPS from CE166α, while nearly normal in amount, also does not contain 
appreciable levels of QuiNAc (8). Thus, these results suggested that QuiNAc, or LPS structural 
features that require QuiNAc, are essential for normal nodulation of bean. An earlier report by 
Hrabak et al. (9) suggested that QuiNAc plays a role in the lectin-mediated interaction of R. trifolii 
with clover. A high level of OPS-containing LPS is essential for symbiotic infection; therefore, the 
synthesis of QuiNAc could play a role in regulating the level of OPS on the bacterial surface and, 
thereby, the symbiotic virulence of R. etli CE3.  
Since QuiNAc is a key glycosyl residue linking the OPS to the core region of the LPS (see 
Fig. 1), it was not understood how mutant CE166 or CE166α could produce LPS that contained 
the OPS but lacked QuiNAc. Here we show that in the LPSs from these mutants, QuiNAc is 
replaced by 2-acetamido-2,6-dideoxyhexosyl-4-ulose, a likely biosynthetic precursor of QuiNAc 
synthesis.  
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Experimental Procedures  
Growth of Bacteria 
R. etli strain CE3, the Tn5-derived mutant CE166, and the suppressed mutant CE166α 
were grown in tryptone/yeast extract supplemented with Ca2+ (10, 11). Bacteria were harvested 
by centrifugation at late log/early stationary phase.  
Isolation of Lipopolysaccharide and the O-specific Polysaccharide 
Lipopolysaccharides were extracted using the hot phenol-water procedure, and purified 
by ribonuclease treatments and size exclusion chromatography (SEC) on Sepharose CL-4B as 
described previously (1, 12). The OPSs were isolated from the total LPS by mild hydrolysis in 
1.0% acetic acid at 105 °C for 2 h. The hydrolysates we re subjected to freeze/thawing (three 
repetitions), and the precipitated lipid A was removed by ultracentrifugation at 160,000 X g for 1 h. 
The supernatants, containing the solubilized O-polysaccharide and the core region 
oligosaccharides, were passed through a column of polymyxin-agarose to remove remaining 
traces of free lipid A and intact LPS (6). The flow-through eluants were then chromatographed on 
Bio-Gel P-10 (45–90-µm fine, 1.5 X 90 cm) in 50 mM ammonium formate, pH 6.5, to separate the 
O-polysaccharides from the core oligosaccharides.  
Analysis of Glycosyl Residues 
Carbohydrate compositions of OPS and derived fractions were determined by gas 
chromatography-mass spectrometry (GC-MS) (electron impact) analysis of the trimethylsilyl 
methyl glycosides (13) using a 30-meter DB-5 fused silica capillary column (J&W Scientific). 
Carbohydrate identities of neutral and amino sugars and the location of endogenous O-methyl 
groups were determined by GC-MS analysis of the alditol acetates, using a 30-meter SP-2330 
capillary column (Supelco) (13). Carboxylated glycosyl residues, and those containing keto 
functions, were also analyzed as the alditol acetates, requiring separate reduction steps in a 
specific sequence: 1) prereduction of OPS at the C-2 ketosidic position of terminal Kdo residues, 
using NaBD4 in dilute NH4OH, yielding the diastereomeric alditols; 2) normal acid hydrolysis (2 M 
trifluoroacetic acid, 105 °C, 3 h) to cleave all glycosi dic linkages and cause formation of the Kdo 
1,4-lactone (14), reduction at C-1 of the Kdo lactone using NaBD4 in water (14), followed by 
reduction of all remaining glycosyl anomeric centers with excess NaBD4; 4) methyl esterification 
of uronic acids (and other remaining carboxylated sugars) using 0.2 M methanolic HCl at 80 °C 
for 30 min; 5) reduction of methyl-esterified sugars with NaBD4 in water; 6) peracetylation. Using 
this multistep procedure, reduction at C-4 of 4-hexulose residues was most efficient, presumably 
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due to the use of three separate reduction steps. Results described below indicate that 
prereduction (step 1), prior to acid hydrolysis and alditol acetate preparation, may be the major 
factor leading to efficient C-4 reduction of the acid-labile 4-hexulose residues. During the 
preparation of alditol acetates by the normal procedure, with only one reduction step following 
acid hydrolysis, the yield of C-4 deuterated derivatives was barely detectable. For glycosidic 
linkage analysis, OPS samples were prereduced with NaBD4 prior to methylation in order to 
stabilize the reducing end residue. Subsequently, Kdo and uronic acid linkages were identified 
by sequential permethylation (Hakomori method), reduction of carboxymethyl groups with lithium 
triethylborodeuteride (Aldrich), remethylation (Hakomori), mild hydrolysis (0.1 M trifluoroacetic 
acid, 100 °C, 30 min) to cleave any internal ketosidi c linkages, reduction (NaBD4), normal 
hydrolysis (2 m trifluoroacetic acid, 121 °C, 2 h), conv ersion to the partially methylated alditol 
acetates (13), and GC-MS analysis. OPS samples that were not prereduced prior to methylation 
failed to yield any Kdo derivatives (due to alkaline degradation of the reducing end Kdo residues) 
and also showed low yields of C-4 deuterium incorporation into the 4-hexulosyl residue.  
Chemical Modifications 
De-O-acetylation of O-polysaccharides was performed in 10% aqueous NH4OH at 23 °C 
for 5 h. The progress of the reaction was followed by 1H NMR and matrix-assisted laser 
desorption ionization-time-of-flight mass spectrometry. Total β-elimination (depolymerization) 
was performed on portions of the native or de-O-acetylated OPS as follows. The polysaccharide 
(8–30 mg) was reduced with NaBD4 (10 mg/3 ml of 0.3 M NH4OH) overnight to stabilize the 
reducing end glycosyl residue and then methyl-esterified by treating three times with methanol 
containing 1–2 drops of aqueous 1 M HCl and evaporating to dryness. The fully esterified 
polysaccharide was then treated with aqueous NaOH (0.25 M,38 °C, 18 h), and the products 
were chromatographed by size exclusion chromatography (SEC) using Bio-Gel P-10 (Bio-Rad) 
(1.5 X 92 cm) in water, or on a Superdex-Peptide HR 10/30 column (Amersham Biosciences) in 
50 mM NH4HCO3. Column eluants were monitored by refractive index and for the presence of 
∆4,5 hexuronosyl residues by measuring the absorbance at 232 nm. Fractions containing 
oligosaccharides were combined and analyzed by electrospray ionization-mass spectrometry 
(ESI-MS) and GC-MS.  
Identification of OPS Reducing End Residue by Reduction with Borodeuteride 
The glycosyl residue located at the reducing end of the various OPS fractions was 
identified by reduction, using borodeuteride in NH4OH as described above, followed by normal 
hydrolysis and peracetylation as described. Derivatives were analyzed using the SP-2330 
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column. This procedure yields the α/β peracetates of all internal residues and the deuterated 
alditol acetate of the reducing end residue.  
Mass Spectrometry 
ESI-MS was performed on a SCIEX API-III triple quadrapole mass analyzer (PE/SCIEX, 
Thornhill, Ontario, Canada) operated in the positive ion mode with an orifice potential of 35–50 V 
(5). Spectra are the accumulation of 10–60 scans collected over the m/z range 200–2400 with a 
mass step of 0.2–1.0 atomic mass units at 1 ms/step. OPS were desodiated by dialysis, followed 
by treatment with a strong cation exchange resin (H+ form), and then filtered using 0.45-µm nylon 
spin filters and stored in polypropylene tubes. Underivatized samples were analyzed at a 
concentration of 2 µg/µl with a flow rate of 3–5 µl/min using a solution of 15% (v/v) methanol in 
deionized water containing 0.5% (v/v) acetic acid. The predicted molecular weights of the various 
OPSs and derived oligosaccharides were calculated using the following average incremental 
mass values, based on the atomic weights of the elements: hexose, 162.1424; hexuronic acid, 
176.1259; 4-deoxyhex-4-enopyranosiduronic acid, 158.1106; Kdo, 220.1791; anhy-dro-Kdo, 
202.1638; 6-deoxyhexose, 146.1430; mono-O-methyl-6-deoxyhexose, 160.1699; 
di-O-methyl-6-deoxyhexose, 174.1968; tri-O-methyl-6-deoxyhexose, 188.2236; 
2-acetamido-2,6-dideoxyhexose, 187.1955; 2-acetamido-2,6-dideoxyhexosyl-4-ulose, 185.1796; 
O-acetyl, 42.0373; free reducing end, 18.0153.  
NMR Spectroscopy 
Proton NMR spectra of the native and de-O-acylated OPS samples were recorded at 
35 °C in D 2O at 2 mg/ml. Spectra were recorded on a Varian 500-MHz spectrometer using the 
Varian software.  
DNA Cloning and Sequence Determination 
The 10.3-kb EcoRI fragment of CE166 DNA carrying the Tn5 insertion was cloned in 
vector pBlueScriptKS- (pBKS) (Stratagene). This plasmid (pET166) was digested with BamHI to 
allow separate subcloning of the inverted repeats at the termini of Tn5 and the rhizobial DNA 
connected to each Tn5 terminus. p166LK is a religated (circularized) BamHI fragment from 
pET166 carrying most of the pBKS and 2.0 kb of rhizobial DNA connected to the Km 
resistance-conferring half of Tn5. Plasmid p166RS is pBKS in which the BamHI site carries 1.2 
kb of rhizobial DNA connected to the other half of the Tn5 from pET166. Sequencing of these 
subcloned rhizobial DNA fragments was carried out by the Sanger method at the University of 
Wisconsin (Milwaukee, WI) and the Medical College of Wisconsin sequencing facilities. Primers 
included sequences near each end of pBKS, near the ends of Tn5, and nucleotide stretches 
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revealed in the rhizobial DNA. Only sequences that were verified by multiple overlapping 
sequencing runs are reported here.  
Construction of Plasmids pJBQ2 and pJBQ3, Which Complement Allele lpsQ166 
A 1.7-kb stretch of DNA that included the lpsQ ORF was amplified by PCR, using CE3 
DNA as template. The forward primer was 5'-TTCATCAGGTCTCACATGCA-3', and the reverse 
primer was 5'-CTTCACTTCGGTACTGTTCG-3'. The resulting PCR product was ligated into 
plasmid pCR2.1 (Invitrogen), yielding plasmid pJBQ1. It was then subcloned into plasmid vectors 
pFAJ1700 (to give pJBQ2) and pFAJ1708 (to give pJBQ3). These vectors can be transferred to 
and replicate in R. etli (15). pJBQ2 was constructed by inserting an EcoRI fragment from pJBQ1 
into the EcoRI site of pFAJ1700. The lpsQ PCR product cloned in pJBQ3 was inserted in 
pFAJ1708 following digestion of both pJBQ1 and pFAJ1708 by enzymes XbaI and SacI such 
that the lpsQ ORF would be transcribed downstream of the nptII promoter of pFAJ1708. 
Plasmids pJBQ2 and pJBQ3 were transferred from E. coli INVαF' cells into strain CE166 in 
mating mixtures containing E. coli MT616 and Tra+ mobilizer plasmid pRK600 (16).  
 
Results  
NMR Analyses and Initial Comparison of the Parent and Mutant Strain O-polysaccharides 
Evaluation of the glycosyl composition of the three different OPSs using standard 
derivatization procedures (trimethylsilyl methyl glycosides and alditol acetates of neutral and 
amino sugars) gave results consistent with previous analyses (5, 8), showing that the OPSs from 
mutants CE166 and CE166α were greatly diminished in QuiNAc (residue B in Fig. 1) compared 
with the parent strain CE3. The finding of detectable levels of QuiNAc in these preparations 
differed somewhat from results previously reported for CE166 OPS in which QuiNAc was 
essentially undetectable (accounting for <5% of parent strain levels) (6). NMR analysis of the 
OPSs (Fig. 2) showed that the ratio of O-acetyl to N-acetyl methyl protons of the CE166 OPS 
was approximately the same as that of the parent; 4.4 versus 4.0. A similar ratio was observed 
for the CE166α OPS (not shown). These results, together with the greatly decreased level of 
QuiNAc, suggested that both mutant OPSs contained an unidentified glycosyl residue that, like 
QuiNAc, carries an N-acetyl group.  
Molecular Size of the Parent and Mutant Strain O-polysaccharides 
ESI-MS analysis (Fig. 3) indicated that all three of the OPSs (as released from LPS by 
mild acid hydrolysis) have a similar molecular mass, each yielding several families of multiply 
charged ions. In Fig. 3A, the parent strain OPS yields two doubly charged ion families (I and II, 
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from high to lower mass, respectively), which differ by 202 mass units (∆ m/z = 101), reflecting 
partial loss of an anhydro-Kdo residue from the reducing terminus of the O-chain. As previously 
reported (5), this loss occurs in approximately one-third of the OPS molecules during the mild 
hydrolytic step and is a function of hydrolysis time. Based on the observed mass differences and 
the known structure of the parent OPS (5), family I ions should consist of molecules terminating 
in anhydro-Kdo, and family II ions should consist of molecules terminating in QuiNAc.  
In Fig. 3B, these two ion families were again observed for the CE166 OPS, together with 
a third ion family (III) not observed in the parent OPS. This new, doubly charged ion family was 
also observed in the CE166α OPS spectrum (not shown). A predominant mass difference 
between representative ions from family II and family III is 187 mass units (∆ m/z = 93.5), 
suggesting the loss of a QuiNAc residue. Thus, family II ions are consistent with the structure R 
→ Fuc → Man → QuiNAc (where R represents OPS repeating units plus capping residue; see 
Fig. 1), and family III ions are consistent with an R → Fuc → Man structure. For the mutant 
samples, the presence of QuiNAc-containing structures was somewhat unexpected, since these 
OPSs contained greatly reduced levels of QuiNAc. However, as stated above, the NMR 
spectrum indicated that the level of N-acetyl groups in the mutant OPS was very similar to that in 
the parent OPS, suggesting that the mutant contained an unidentified component, “X,” which 
was N-acetylated. Aside from variations arising from O-acetyl and methyl group content, the 
similar m/z values of the mutant OPS ions with those of the parent imply that compound X would 
have a mass very similar to that of QuiNAc. If this were the case, then the mutant group I ions 
would consist of a mixture of R → Fuc → Man → QuiNAc → anhydro-Kdo and R → Fuc → Man 
→ X → anhydro-Kdo components, and the group II ions would arise from the structures R → Fuc 
→ Man → QuiNAc and R → Fuc → Man → X, assuming that X was a direct replacement for the 
QuiNAc residue.  
One explanation for the existence of the group III ions in the mutant spectra is that the 
unidentified component is somewhat labile to the mild acid hydrolysis conditions and is partially 
removed during this procedure. A second possibility is that the mutant is able to form an R → Fuc 
→ Man → Kdo sequence rather than the normal R → Fuc → Man → QuiNAc → Kdo due, for 
example, to the direct addition of Man II to Kdo III (residues A and C in Fig. 1) by the inner core 
LpcC mannosyl transferase. If this were the case, then, considering the specificity of LpcC, the 
Man II residue would be linked to O-5 of Kdo III. However, methylation analysis (not shown) 
showed that the mutant OPS contained only the expected 4-linked Kdo, making it unlikely that 
LpcC adds a Man to Kdo III.  
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Identification of 2-Acetamido-2,6-dideoxyhexosyl-4-ulose  
The NMR and mass spectrometry data suggested that the mutant OPSs contained an 
unidentified, N-acetylated component, having a mass very similar to that of QuiNAc. As stated 
above, composition analyses using standard derivatization procedures failed to reveal any 
significant differences among the polysaccharides aside from the aforementioned reduction in 
QuiNAc in both mutant OPSs. Considering the possibility that the unidentified component might 
also contain a carboxyl or other carbonyl function, in addition to the proposed N-acetyl group, the 
“carboxyl-reduced” alditol acetates were prepared and analyzed. The results (Table I) confirmed 
that the OPSs from CE166 and CE166α are greatly diminished in QuiNAc, as expected. 
Interestingly, a series of new glycosyl residues were observed that were present only in the 
mutant OPSs. These residues were identified from their mass spectra as structural 
(configurational) isomers of QuiNAc. The GC-MS profiles and representative spectrum of these 
components are shown in Fig. 4 and are consistent with alditol acetates of various 
2-acetamido-2,6-dideoxyhexosyl residues (epimers, having different retention times) each 
containing a single deuterium atom at C-4. Such residues would result from borodeuteride 
reduction of a 2-acetamido-2,6-dideoxyhexosyl-4-ulose residue. As shown by methylation 
analysis (see below), the deuterium was located exclusively at C-4 in all epimer derivatives. Thus, 
nonstereospecific reduction at C-4 would yield both the 4-deuterio-QuiNAc, (confirmed by its 
mass spectrum and co-chromatography with authentic QuiNAc) and its galacto isomer 
(N-acetyl-4-deuteriofucosamine). The two remaining C-4-deuterated derivatives are derived from 
reduction of the 4-ulose C-3 epimer, which most likely results from keto-enol isomerization of the 
4-ulose residue prior to or during reduction.  
The three OPS samples were prereduced (to stabilize the reducing end residue) and 
subjected to methylation analysis. The parent strain OPS yielded only the expected 3-linked 
QuiNAc derivative as reported previously (5). However, both mutant OPSs contained a series of 
new derivatives, representing the epimers of the 3-linked QuiNAc residue. The mass spectra of 
each derivative revealed that all epimers were deuterated at C-4, and all were 3-linked, each 
yielding a partially methylated alditol acetate, 
2-N-methylacetamido-1,3,5-tri-O-acetyl-4-O-methyl-1,4-di-deuterio-2,6-dideoxyhexitol (having 
different configurations) as evidenced by primary fragment ions m/z 159, 289, 276, and 132 (data 
not shown). Each of the latter three ions is 1 mass unit higher than the corresponding ions 
derived from the nondeuterated parent strain compound and conclusively localizes deuterium 
attachment to C-4. Secondary ions m/z 202 (from 276) and m/z 90 (from 132) further prove the 
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location of deuterium to be C-4. Together these results show that a 3-linked 
2-acetamido-2,6-dideoxyhexosyl-4-ulose residue occurs in the mutant OPS and is consistent 
with the conclusion that, in the mutant structure, it has replaced the 3-linked QuiNAc residue of 
the parental OPS.  
Labeling and Identification of the Reducing End Residue 
In order to identify the glycosyl residues at the reducing end of the various OPS, samples 
were reduced with borodeuteride and then hydrolyzed and acetylated, yielding the α/β 
peracetates of all internal residues and the deuterated alditol of the reducing end residue. A 
comparison of the results obtained for the parent and mutant strain OPSs is shown in Fig. 5. The 
parent strain (Fig. 5B) yielded the α/β peracetates of QuiNAc (originating from molecules 
terminating in Kdo) and the alditol of QuiNAc, indicating that a portion of the parent OPS lacked 
Kdo, thereby terminating at the reducing end with QuiNAc. These results are consistent with the 
ESI-MS analyses (Fig. 3A) showing that the parent OPS preparation contains two families of ions 
consistent with R → Fuc → Man → QuiNAc → Kdo and R → Fuc → Man → QuiNAc structures. 
The mutant OPS (Fig. 5A) preparations yielded the α/β peracetates of QuiNAc (originating from 
molecules terminating in Kdo), the alditol of QuiNAc (originating from molecules terminating in 
QuiNAc), and substantial amounts of the alditol of Man (from molecules terminating in Man). In 
addition, the QuiNAc alditol detected in the mutant OPS co-eluted with a small percentage of its 
C-4 deuterated analogue (2-acetamido-4-deuterio-2,6dideoxyglucitol), as evident from the mass 
spectra (analogous to that shown in Fig. 5). The occurrence of the C-4-deuterated alditol 
supports the conclusion that the 2-acetamido-2,6dideoxyhexosyl-4-ulose residue is at the same 
location in the mutant OPS as is QuiNAc in the parent OPS. In the mutants, the presence of OPS 
molecules terminating in Man (Fig. 3B)or Man-ol (following reduction) (Fig. 4) is again attributed 
to acid lability of the 4-hexulose residue. The low yield of 4-deuterio-HexNAc derivatives 
observed in the mutant OPS using this protocol is probably due to incomplete reduction of the 
4-keto group (due to only a single reduction step) and subsequent degradation, resulting in OPS 
with the reducing end Man residue. Thus, the unique structures observed in the mutant OPS are 
R → Fuc → Man, R → Fuc → Man → X, and R → Fuc → Man → X → Kdo.  
Depolymerization of the OPSs and Analysis of Oligosaccharides 
To further characterize the outer core glycosyl sequence at the reducing end of the 
mutant OPSs, the OPSs were subjected to alkali-catalyzed β-elimination. It was previously 
shown that treating the parent strain OPS with alkali causes β-elimination of the uronosyl 
residues, leading to depolymerization of the repeating units and leaving the nonrepeating 
10  Forsberg, Noel, Box, & Carlson 
 
oligosaccharide regions of the OPS, lacking uronic acid, essentially intact (5). In the case of the 
parent OPS, these nonrepeating, alkali-stable regions consist mainly of glycosyl sequences that 
originate from the reducing end of the OPS (e.g. R → Fuc → Man → QuiNAc → Kdo, where R 
represents variable portions of a single OPS repeating unit, and Kdo represents the inner core 
Kdo III residue) (5). Further, partial β-elimination of the 3-linked QuiNAc residue may also occur 
during this procedure (5); nevertheless, there is enrichment of the outer core oligosaccharide 
region of the OPS due to degradation of the OPS repeating units.  
This procedure was applied to both the CE166 and CE166α OPS, and the resulting 
alkali-resistant oligosaccharides were fractionated by SEC and then analyzed by ESI-MS, 
glycosyl composition, and linkage analyses. Two major SEC fractions were obtained for both the 
CE166 and CE166α mutants, and their ESI-MS spectra are shown in Fig. 6. Each SEC fraction 
consisted of a number of oligosaccharides, and their observed ions and proposed formulas are 
summarized in Table II. Both mutant OPS yielded several unique oligosaccharides, in addition to 
products identified previously in the parent OPS (5). One of these unique oligosaccharides 
(OS-1) has a mass (m/z 794.5) supporting a R → Fuc → Man-ol structure, consistent with the 
data described above. This oligosaccharide was abundant in the mutant spectra, particularly in 
the lower molecular weight SEC fraction (Fig. 6B), and was detected only at low levels in the 
parent strain spectrum (not shown). Other oligosaccharides, detected only in the mutant spectra, 
include the species at m/z 982.5 (OS-3, R → Fuc → Man → 6-deoxy-4-deuterio-HexNAc-ol), m/z 
1181.8 (OS-7, R → Fuc → Man → 6-deoxy-4-deuterio-HexNAc → anhydro-Kdo), and m/z 
1202.8 (OS-9, R → Fuc → Man → 6-deoxy-4-deuterio-HexNAc →Kdo-ol) (Fig. 6A). These ions 
are shifted 1 mass unit higher than their parent strain counterparts, consistent with the presence 
of a 4-C deuterio analogue of QuiNAc. The nondeuterated oligosaccharides, which contain 
QuiNAc, are also observed in the mutant spectra (compare OS-6 at m/z 1180.8 versus OS-7 at 
m/z 1181.8, and compare OS-8 at m/z 1201.8 versus OS-9 at m/z 1202.8). The presence of a 
6-deoxy-4-deuterio-HexNAc residue in OS-7 and OS-9 is consistent with the results described 
above that show borodeuteride reduction at C-4 of the hex-4-ulosyl residue. In Fig. 6, the 
spectrum shows that the ion intensity of R → Fuc → Man → QuiNAc → anhydro-Kdo (m/z 
1180.8) is greater than that of R → Fuc → Man → 6-deoxy-4-deuterio-HexNAc → anhydro-Kdo 
(m/z 1181.8). This result was not consistent with the composition data, which show that the 
mutant OPS contains only a low level of QuiNAc. However, as described above, a possible 
explanation of this apparent discrepancy is that the 4-keto group of 
2-acetamido-2,6-dideoxyhexosyl-4-ulose is only partially reduced during the single prereduction 
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step prior to the β-elimination and ESI analysis, and the remaining nonreduced hex-4-ulose 
residue is subsequently degraded during the alkaline treatment. Since oligosaccharides 
containing the 2-acetamido-2,6-dideoxyhexosyl-4-ulose residue would show a decrement of 2 
mass units compared with their normal counterparts (i.e. those containing QuiNAc), degradation 
of the 2-acetamido-2,6-dideoxyhexosyl-4-ulose residue would also account for the absence of 
any molecular species having a mass decrement of 2 mass units.  
The Genetic Locus Mutated in Strain CE166 
DNA carrying the Tn5 insertion in CE166 was cloned, and the sequence of a stretch of 
2971 nucleotides was determined, as summarized in Fig. 7A. The Tn5 had inserted within an 
ORF designated as lpsQ that encodes a hypothetical polypeptide of 309 amino acids. The 
predicted LpsQ amino acid sequence falls within the large WcaG family of epimerases and 
reductases involved in deoxyhexose synthesis (www.ncbi.nlm.nih.gov/Structure/cdd/). Matched 
against ORF translation products whose functions have been studied by mutation analysis, LpsQ 
shows the greatest sequence alignment with WbpV and WbpK of Pseudomonas aeruginosa 
serotypes O6 and O5 (17). All three predicted proteins align throughout their sequences (Fig. 7B), 
the closest alignment being between WbpV and LpsQ (47% identity, 64% similarity). As noted in 
Fig. 7B, LpsQ and its homologs have the GXXGXXG motif for binding NAD(P) and a triad of 
amino acids (SXnYX3K) that are conserved among ORFs in the WcaG family. These latter three 
amino acids are at the active sites of WcaG (GDP-4-keto-6-deoxy-D-mannose 
epimerase/reductase) (18), GalE (UDP-galactose 4-epimerase) (19), and most of the studied 
examples within the larger family of short-chain dehydrogenases/reductases (20).  
lpsQ is flanked by two ORFs homologous to highly conserved eubacterial genes, murB 
and ddlB, whose transcription is oriented oppositely to that of lpsQ (Fig. 7A). murB and ddlB are 
involved in peptidoglycan synthesis and are generally contiguous in the genomes of other 
α-proteobacteria (21–24); murB encodes UDP-N-acetylmuramate dehydrogenase, and ddlB 
encodes D-alanylalanine synthase. The 63 amino acids encoded by the deduced ddlB fragment 
were 76% identical and 87% similar to the N-terminal 63 amino acids encoded by the presumed 
ddlB of Sinorhizobium meliloti (25). The 279 amino acids encoded by the deduced murB 
fragment were 76% identical and 87% similar to the corresponding C-terminal amino acids 
encoded by the presumed murB of S. meliloti (25).  
A PCR product from wild-type R. etli strain CE3 containing lpsQ that extends from 
nucleotide 260 to 1969 in Fig. 7A, was cloned into broad host vectors pFAJ1700 and FAJ1708. 
When either construct was transferred into strain CE166, normal LPS I abundance, normal 
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QuiNAc content, and normal symbiotic proficiency were restored (data not shown).  
 
Discussion 
The OPSs released by mild acid hydrolysis of the LPSs from the R. etli CE3 mutants, 
CE166 and CE166α, were shown to have the following structures: R → Fuc → Man → QuiNAc 
→ Kdo (1), R → Fuc → Man → QuiNAc (2), R → Fuc → Man → X → Kdo (3), R → Fuc → Man 
→ X(4), and R → Fuc → Man (5), where R represents the repeating unit oligosaccharide and 
capping residue as shown in Fig. 1 and where X has been identified as 
2-acetamido-2,6-dideoxyhexosyl-4-ulose. The low levels of QuiNAc in these mutant LPSs imply 
that structures 1 and 2 are present in minor amounts. Structures 2 and 4 are due to the 
elimination of Kdo from a portion of the molecules during the mild acid hydrolytic release of OPS 
from the LPS; partial loss of this Kdo has also been reported as occurring during isolation of the 
parent strain OPS (5). Structure 5 is probably due to the elimination of the 
2-acetamido-2,6-dideoxyhexosyl-4-ulose residue, also during the mild acid hydrolysis 
procedure. From these results it can be concluded that the R. etli CE3 mutants, CE166 and 
CE166α, produce LPSs in which the outer core oligosaccharide has two structures, 6 and 7, 
shown in Fig. 8. Structure 6 is normally found in the OPS from the parent strain, whereas 
structure 7 is found in the mutant OPSs and is not present in the parent. In structure 7, the 
QuiNAc is replaced by 2-acetamido-2,6-dideoxyhexosyl-4-ulose. Although rare in 
polysaccharides, 2-acetamido-2,6-dideoxy-D-xylo-hexos-4-ulose was first identified as a 
component of the pentasaccharide repeating unit in the capsular polysaccharide synthesized by 
Streptococcus pneumoniae type 5 (26). In LPS, two occurrences of this glycose have been 
reported, as a component of the tetrasaccharide repeating unit in the OPS from Vibrio ordalii 
serotype O:2 (27) and recently in the OPS repeating unit from Flavobacterium columnare ATCC 
43622 (28). In all reported occurrences, the glycose is 3-linked and is part of a repeating unit 
that comprises a polysaccharide. In the case of the R. etli CE166 mutant, the glycose occurs as 
a single residue in the outer core portion and is not part of the OPS repeating unit. To our 
knowledge, this is the first example of a core region glycose residue being replaced by its 
biosynthetic precursor.  
The relative amounts of these two structures present in these LPS preparations from 
CE166 and CE166α can be estimated from the composition data shown in Table II. This 
calculation is based on the assumption that the OPS from the parent exists exclusively as 
structure 6 and, therefore, that the level of QuiNAc in the parent OPS represents the total molar 
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fraction amount of QuiNAc present in an OPS preparation in which all molecules contain QuiNAc. 
Thus, in CE166 the percentage of structure 6 can be calculated from the mutant to parent molar 
QuiNAc ratio (see Table I), 0.13/0.62 or 21%, which implies that structure 7 comprises the 
remainder of the CE166 LPS, or 79%. Similarly, in the CE166α OPS, the percentages of 
structures 6 and 7 are 10% (0.06/0.62), and 90%, respectively.  
The presence of small amounts of structure 6 in the mutant OPSs is a slightly different 
result from what would have been predicted from our previous report (8) in which the LPSs from 
CE166 and CE166α did not contain detectable levels of QuiNAc. One possible explanation for 
this difference in the two preparations is reversion. Initial studies with this mutant indicated that at 
low frequency it underwent an unusual type of reversion in which the Tn5 ended up in another 
replicon of the bacterium (29). Later studies could not reproduce this result. A second related 
possibility is extragenic suppression. Suppressor mutations may allow detectable QuiNAc 
synthesis by occurring in a second, cryptic copy of lpsQ or a gene encoding a 4-reductase 
normally involved in synthesis of another deoxysugar. Both of these possibilities would be 
consistent with not observing QuiNAc in some cases (8) and observing a small amount in other 
cases (3). It should also be noted that the CE166α LPS, while containing almost parental levels 
of OPS, has much less QuiNAc than does the mutant CE166 LPS. Thus, whereas the current 
results are not identical to those previously reported with regard to the level of QuiNAc, it is clear 
that the lps-166 mutation results in an LPS that is very deficient in the level of QuiNAc and, 
therefore, in the amount of the normal parental structure 6.  
In the major mutant structure 7, the QuiNAc residue normally present in the parental LPS 
(i.e. structure 6) has been replaced by its presumed 4-keto precursor, 
2-acetamido-2,6-dideoxyhexosyl-4-ulose. Since QuiNAc is an essential sugar involved in joining 
the OPS to the core region of the LPS, the presence of the 4-keto precursor in place of QuiNAc 
suggests that the UDP-QuiNAc transferase is able to use 
UDP-2-acetamido-2,6-dideoxyhexosyl-4-ulose as a substrate. The lower level of OPS in CE166 
compared with that in the parent CE3 would imply that this transferase uses 
UDP-N-acetyl-2-amino-6-deoxyhexosyl-4-ulose less efficiently than UDP-QuiNAc; i.e. it is likely 
not to recognize the 4-ulose as well as QuiNAc. The fact that CE166α, which contains multiple 
copies of the lps α-region, produces LPS with close to the normal level of OPS but containing 
N-acetyl-6-deoxyhexosyl-4-ulose in place of QuiNAc suggests that this transferase may be 
located on the lps α-region, and its overexpression allows more OPS to be made and 
subsequently added to the LPS core region.  
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The suggested biosynthetic pathway of D-QuiNAc is shown in Fig. 9. In this pathway, 
UDP-GlcNAc is converted into UDP-QuiNAc by two enzymatic activities: a 4,6-dehydratase, 
which forms UDP-N-acetyl-6-deoxyhexosyl-4-ulose from UDP-Glc-NAc, and a reductase, which 
stereospecifically reduces UDP-N-acetyl-6-deoxyhexosyl-4-ulose to UDP-QuiNAc. This work 
provides evidence for the assignment of LpsQ to the second step of QuiNAc synthesis (Fig. 9), 
since the lpsQ mutation allows the synthesis of the keto intermediate and highly abrogates the 
production of QuiNAc itself.  
In vitro studies with two proteins have indicated that a single enzyme may catalyze both 
of the above steps in the synthesis of D-QuiNAc from D-GlcNAc (30–32). These two proteins are 
encoded by genes wbpM of P. aeruginosa (30) and flaA1 of Helicobacter pylori (31). However, 
the predicted LpsQ ORF exhibits very little sequence similarity to these proteins. In paired 
comparisons by the Blast2 program (www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html), the FlaA1 
sequence yields an alignment with LpsQ of low significance (“expect value” e-3), and this 
program finds no significant overall homology between LpsQ and WbpM. By contrast, FlaA1 and 
WbpM sequences align in a clearly significant manner (giving an expect value of 2e-25). They 
would appear to be in a different subfamily of the NDP-sugar dehydratase/epimerase/reductases 
within the larger family of short-chain dehydrogenase/reductases (20). There is also a recently 
proposed pathway for synthesis of L-QuiNAc, involving five steps catalyzed in vitro by three 
enzymes (33). In Blast2 and ClustalW analysis, LpsQ shows little or no significant sequence 
similarity to any of the proteins thus far assigned to this pathway.  
Despite the existence of the apparently bifunctional enzymes WbpM and FlaA1, it still 
seems plausible that QuiNAc may be synthesized through the action of two separate enzymes, a 
dehydratase and a reductase (Fig. 9). However, if such is the case in R. etli, it is surprising that 
the gene for the first step (the hydratase) appears not to be contiguous with lpsQ. It was already 
surprising that lpsQ was not closely linked with other genes of R. etli CE3 that are required for its 
LPS core and O-antigen (3, 8, 34). However, it should be pointed out that many of the genes for 
LPS core synthesis in R. etli have not been identified. It also should be pointed out that R. etli 
appears to be especially prone to gene duplications and transpositions of small and long 
segments of DNA (29). There may be another (less active) copy of lpsQ, which is contiguous 
with an unduplicated gene that specifies the first step in Fig. 9. lpsQ appears to reside within a 
suite of cell wall synthesis genes. Generally, murB and ddlB are contiguous in other 
α-proteobacteria; however, there is precedent for an insertion between them. In S. meliloti, two 
hypothetical genes have been inserted between ddlB and murB (25). These two hypothetical 
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genes, coding for an aquaporin and a possible transport protein, as with lpsQ, are also not 
related to cell wall synthesis proteins. It is possible that this site may be a target for a type of 
transposition event that inserts various genes.  
A number of subtle structural changes have been reported to occur to the OPS portion of 
R. etli CE3 LPS during symbiosis. These changes have been detected using monoclonal 
antibodies that are specific to the OPS portion of the LPS and involve methylation of the Fuc 
residues (8, 13, 35). During nodulation, the reactivity of the OPS for two of four mAbs greatly 
decreases (36). The binding of these mAbs involves, in part, the terminal capping TOMFuc 
residue (35) and a 2MeFuc residue2 either in the repeat unit or in the outer core region (see the 
structure shown in Fig. 1). The CE166 and CE166α mutants do not differ from the parent with 
regard to their ability to bind these mAbs, and therefore, there apparently is no difference from 
the parent OPS in these fucosyl residues. Indeed, strain CE166α (8) produces parental levels of 
OPS, which, while deficient in QuiNAc, has a structure that is otherwise the same as the parent 
CE3 OPS as reflected by composition, mass spectrometric, NMR, and monoclonal antibody 
binding data (this report) (8). This very minor chemical change (i.e. replacement of QuiNAc with 
its 4-keto precursor) results in an altered nodulation phenotype (i.e. nodulation is delayed, and 
the distribution of nodules is altered) (8), suggesting that it produces a structural change that is 
significant enough to affect its role in symbiosis. In addition, this result suggests that structural 
features of this outer core region of CE3 LPS, in addition to changes in the methylation pattern of 
TOMFuc and Fuc residues, are involved in establishing symbiosis with the host legume.  
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Appendix 
Table 1 
Glycosyl composition of R. etli parent and mutant strain O-polysaccharides as determined by 
GC-MS analysis of the derived, carboxyl-reduced, alditol acetates  
 
Glycosyl reside Molar ratio
a 
CE3 CE166 CE166-α 
2,3,4-MeFuc 0.98 0.59 0.90 
2,3-MeFuc 0.0 0.64 0.12 
2-MeFuc 0.63 0.88 0.52 
3-Me-6-deoxyTalb 4.30 4.10 3.81 
Fuc 3.87 3.56 2.80 
Man 1.00 1.00 1.00 
GlcAc 3.84 3.98 3.08 
Kdod 0.71 0.93 1.04 
QuiNAc 0.62 0.13 0.06 
6-dexoxy-4-D-HexNAce  0.38 0.50 
 
aRatios normalized to Man, determined from the GC-MS total ion current peak areas of the alditol acetates 
with response factor correction from authentic standards. Partially methylated standards of 
6-deoxytalose were obtained from a Streptococcal type-specific polysaccharide, and the R. etli parent 
strain OPS served as a source of authentic QuiNAc as previously described (5).  
b3-Me-6-deoxyTal, 3-O-methyl 6-deoxytalose.  
cDetermined as the carboxyl-reduced alditol acetate, containing two deuteriums at C-6.  
dDetermined as the carboxyl-reduced alditol acetate, containing two deuteriums at C-1.  
eD-HexNAc, 2-acetamido-2,6-dideoxyhexose, determined as the keto-reduced alditol acetate, derived 
from the corresponding hex-4-ulose and containing one deuterium atom at C-4  
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Table 2  
Ions derived from electrospray analysis and proposed formulas of the reducing end oligosaccharides produced from 
β-elimination of the R. etli mutant strain CE166 OPS  
 
Observed 
iona 
Experimental 
mass 
 Calculated mass and proposed formulab Predicted 
ionc 
794.5 793.5 OS-1 M + H+1 794.8 
793.8 + H+1 [∆4,5GlcA13Me6dTal1Fuc2Man-ol1] + H+ 
981.5 980.5 OS-2 M + H+1 982.0 
980.9 + H+1 [∆4,5GlcA13Me6dTal1Fuc2Man1QuiNAc-ol1] + H+ 
982.5 981.5 OS-3 M + H+1 983.0 
981.9 + H+1 [∆4,5GlcA13Me6dTal1Fuc2Man14-D-HexNAc-ol1] + H+ 
1020.5 1019.5 OS-4 M + H+1 1020.9 
1019.9 + H+1 [∆4,5GlcA1Fuc2Man1QuiNAc12,7anhydKdo1] + H+ 
1041.5 1040.5 OS-5 M + H+1 1042.0 
1040.9 + H+1 [∆4,5GlcA1Fuc2Man1QuiNAc1Kdo-ol1] + H+ 
1180.8 1179.8 OS-6 M + H+1 1181.1 
1180.1 + H+1 [∆4,5GlcA13Me6dTal1Fuc2Man1QuiNAc12,7anhydKdo1] + H+ 
1181.8 1180.8 OS-7 M + H+1 1182.1 
1181.1 + H+1 [∆4,5GlcA13Me6dTal1Fuc2Man14-D-HexNAc12,7anhydKdo1] + H+ 
1201.8 1200.8 OS-8 M + H+1 1202.1 
1201.1 + H+1 [∆4,5GlcA13Me6dTal1Fuc2Man1QuiNAc1Kdo-ol1] + H+ 
1202.8 1201.8 OS-9 M + H+1 1203.1 
1202.1 + H+1 [∆4,5GlcA13Me6dTal1Fuc2Man14-D-HexNAc1Kdo-ol1] + H+ 
 
aA mass step of 0.2 atomic mass units was used during analysis.  
bCalculated from the average incremental mass of the component glycosyl residues as described under “Experimental Procedures.” The proposed 
formulas of OS-6 and OS-8 are identical to those detected in the parent OPS (5). Glycosyl composition and linkage analysis of the mutant SEC 
fractions resulting from β-elimination confirmed the presence of 3-linked Man-ol, 3-QuiNAc-ol, and 3-(4-D-HexNAc) in the appropriate SEC 
fractions (data not shown). Oligosaccharides OS-4 and OS-5 appear to arise from OS-6 and OS-8, respectively, due to loss of a terminal 
3Me6dTal residue; the 3Me6dTal is linked 1 → 3 to fucosyl residues in OS-6 and OS-8 (5). ∆4,5GlcA, 4-deoxyhex-4-enopyranosiduronate; 
3Me6dTal, 3-O-methyl-6-deoxytalose; 2,7anhydKdo, 2,7-anhydro-Kdof; Kdo-ol, Kdo reduced at C-2 with borodeuteride; Man-ol, Man reduced at 
C-1 with borodeuteride; QuiNAc-ol, QuiNAc reduced at C-1 with borodeuteride, etc.  
cThe predicted singly charged ion as determined from the proposed formula. 
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Figure 1  
The complete glycosyl sequence of the carbohydrate portion of R. etli CE3 LPS 
 
The OPS portion contains a nonrepeated trisaccharide at its reducing end defined as the outer core 
(residues B–D) that links the repeating units to the inner core region. Mild hydrolytic treatment of the LPS 
cleaves at ketosidic linkages, and the released OPS terminates in Kdo (residue A). The extent of 
O-methylation of the fucosyl residues is indicated (5).  
 
Figure 2  
The proton NMR spectra of the OPS from R. etli CE3 LPS (A) and the OPS from R. etli 
CE166 LPS (B)  
 
The resonances for the anomeric, methoxyl, C-6 
methyl, and N- and O-acetyl methyl protons are as 
indicated. 
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Figure 3  
Positive ion ESI-MS spectra of the intact (native) OPS released by mild hydrolysis from 
the parent strain CE3 (A), and the CE166 mutant (B).  
 
Protonated doubly and triply 
charged ions are observed in both 
spectra. Among doubly charged 
ions (M + 2H)2+, ions within each 
family differ by ±7 m/z (14 mass 
units), reflecting heterogeneity in the 
degree of endogenous 
O-methylation. The triply charged 
ions differ by 4.7 m/z (rounded to 
∆=5 m/z as shown). In A, the 
observed ion m/z 1749 
(experimental mass 3496) 
corresponds to a molecular 
component (lactone form) having 
the following formula: 
TOMeFuc1GlcA4(OAc)4-GlcAMe13M
e6dTal5Fuc52MeFuc1Man1-QuiNAc1 
anhydro-Kdo1 (calculated mass 
3494.3, predicted ion 1748.2). The 
electrospray technique tends to 
induce lactonization of carboxylated 
polysaccharides, resulting in a loss 
of a single H2O from such species, 
presumably at the Kdo (or a GlcA) 
residue. Variation in O-acetyl 
content (± m/z 21; 42 mass units) 
also contributes to the multiplicity of 
ions within each family. B, the 
somewhat higher m/z values for the 
mutant, compared with the parent 
OPSs are consistent with an 
increase in O-acetyl and/or methyl 
groups (e.g. m/z 1784 compared 
with 1749 can be accounted for by 
one additional O-acetyl (+m/z 21) 
and two additional methyl groups 
(+m/z 14). Such differences could 
arise from variations in the mild acid 
hydrolysis conditions, storage time 
of the OPS in solution, or normal 
batch to batch variations in LPS. In 
B, the CE166 mutant OPS contains 
a third ion family, representing one 
aspect of the mutation (see 
“Results”). The spectrum of the CE166α OPS (not shown) is similar to that of CE166. Q, QuiNAc; X, 
analogue of QuiNAc; M, mannose; K, anhydro-Kdo; R, the repeating unit portion of the OPS. The anhydro 
forms of Kdo are generated during the mild hydrolytic release of OPS (5).  
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Figure 4  
GC-MS analysis of the amino 
sugar components in parent and 
mutant strain OPSs 
A, comparison of the total ion 
chromatograms of the carboxyl-reduced 
alditol acetates derived from the parent 
(top) and CE166 mutant (bottom) OPSs; 
the arrows mark the location of 
deuterated analogues of QuiNAc. Minor 
components eluting between 52 and 57 
min are by-products of the Kdo 
derivatization. B, electron impact mass 
spectrum and fragmentation scheme of 
one of the deuterated amino sugar 
analogues detected in the CE166 and 
CE166α mutant OPSs. It is noteworthy 
that traces of the C-4 deuterated alditols 
were also detected during the 
preparation of the normal alditol 
acetates; however, their yields were 
increased during preparation of the 
carboxyl-reduced derivatives, a 
procedure that involves two additional 
treatments with borodeuteride (see 
“Experimental Procedures”). 
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Figure 5  
Labeling and comparison of the reducing end residues of the OPSs by GC-MS analysis  
 
 
The native OPSs were reduced with borodeuteride and then hydrolyzed and acetylated, yielding the 
peracetates of all internal residues and the deuterated alditols of the reducing end residues. A, the CE166 
mutant OPS yields a small amount of QuiNAc-ol, co-eluting with 4-deuterio-QuiNAc-ol (identified from the 
mass spectrum of its alditol acetate), and Man-ol. The α/β peracetates of QuiNAc, and 4-deuterio-QuiNAc 
(which co-elute) were also observed; B, the parent strain OPS yielded primarily the QuiNAc α/β 
peracetates and lesser amounts of QuiNAc-ol, confirming the structural assignments for the ion families 
obtained by ESI-MS (see Fig. 3). The Kdo alditol derivative, visible in Fig. 4, is not produced under these 
conditions (see “Experimental Procedures”). All three OPS samples contained a percentage of molecules 
terminating in Kdo, revealed by the “carboxyl-reduced alditols” (Fig. 4) and by the ESI-MS analysis (Fig. 3).  
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Figure 6 
Positive ion ESI-MS spectra of oligosaccharides derived from base-catalyzed β
-elimination of the CE166 mutant OPS.  
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The OPS was prereduced with borodeuteride to stabilize the reducing end to alkali, subjected to 
β-elimination, and fractionated by SEC. The two major SEC fractions were analyzed: the higher molecular 
weight fraction that is enriched in oligosaccharides originating from the reducing end of the OPS and 
terminating in anhydro-Kdo or Kdo-ol (A) and the lower molecular weight fraction that is enriched in 
reducing end oligosaccharides terminating in Man-ol, QuiNAc-ol, or 
2-N-acetamido-4-deuterio-2,6-dideoxyhexitol (B). These oligosaccharides represent different forms of the 
reducing end of the OPS; all reducing end residues have been reduced with borodeuteride except for 
those terminating in 2,7-anhydro-Kdo residues, which arise during the mild hydrolytic release of the OPS 
(5) and resist reduction. All of these oligosaccharides terminate at the nonreducing end with a 
4-deoxyhex-4-enopyranosyluronic acid residue, resulting from elimination of the 4-O-substituent from the 
glucuronosyl residues (5). All molecular ions are of the formula (M + H)1+, and their structures are 
summarized in Table II. Oligosaccharides originating from the nonreducing end of the OPS co-eluted 
during SEC and are also visible in the spectra; their masses and structures are identical to those described 
previously for the parent OPS (5) and include species at m/z 703, m/z 689, m/z 543, and m/z 529. The ion 
(*) is a contaminant in the solvent.  
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Figure 7 
A, the DNA locus mutated in strain CE166  
The numbers refer to nucleotides, with position 1 on the leftmost end being the first of the 2971 nucleotides 
whose sequence was determined at this locus. A stretch of 34 nucleotide pairs upstream of ddlB 
(nucleotides 431–465) are almost exactly conserved between S. meliloti, Agrobacterium tumefaciens, and 
this R. etli sequence. This stretch is probably the promoter for ddlB; it has a very strong match with 
consensus σ70-type promoters. A weaker match with σ70-type promoters, oriented toward lpsQ, is 
indicated by P?. Above the predicted ORFs is shown the expanse of DNA that was amplified from 
wild-type strain CE3 by PCR, which restores CE166 to LpsQ+ phenotypes when cloned in vectors 
pFAJ1700 and pFAJ1708. B, alignment of the predicted LpsQ amino acid sequence with the sequences of 
two homologs from P. aeruginosa by use of the ClustalW program (37) (available on the World Wide Web 
at www.ebi.ac.uk/clustalw/index.html). Boldface letters within shaded areas indicate the GXXGXXG motif 
for NAD(P) binding and the SXnYX3K residues commonly found at the active sites of enzymes in the SDR 
superfamily (e.g. residues 114, 139, and 143 of LpsQ). The boxed string of identical residues near the C 
terminus may participate in substrate specificity. It differs greatly from a stretch of residues that are 
conserved among fucose synthetases at the same place in alignments of the polypeptide sequences (38).  
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Figure 8  
The outer core structures observed in the LPSs from R. etli CE3, and mutants CE166 and 
CE166α 
R represents the capping and repeating unit portion of the OPS (refer to Fig. 1 for the complete structure of 
the OPS).  
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Figure 9  
The suggested biosynthetic scheme for the synthesis of UDP-QuiNAc  
 
